Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy Surgery
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the analgesic efficacy, on Post-Operative
Day (POD) 1, of DEX-IN compared with placebo, using the summed pain intensity difference over
the first 48 hours (SPID48) in subjects with acute moderate to severe pain following
unilateral bunionectomy.